Pharmacology for Nurses · Transgender and Nonbinary Drugs
Masculinizing Hormonal Therapy
On this page 9 sections
In 30 seconds
Masculinizing hormonal therapy helps transgender men and some nonbinary people develop male secondary sex characteristics and suppress estrogen-driven features such as menstruation. The core drug is Testosterone The main human androgen; the drug used in masculinizing therapy Full entry →, given in injectable, transdermal (gel or patch), buccal, or subcutaneous pellet forms. Testosterone works through androgen receptors to produce virilizing effects — voice deepening, facial and body hair growth, increased muscle mass, fat redistribution, and cessation of menses — and a portion is converted to estradiol by the enzyme Aromatase The enzyme that converts testosterone into estradiol Full entry →, which shapes the overall effect. Therapy is prescribed and monitored by a licensed provider under current standards of care or informed-consent protocols. The nurse's work is teaching safe administration — especially injection technique and gel-handling precautions — and watching for key risks, most notably Erythrocytosis Too many red blood cells (elevated hematocrit) Full entry → (too many red blood cells). This is an educational draft: drug classes and mechanisms only — never doses, schedules, or administration recommendations; verify everything against current references, the institutional formulary, and prescriber orders.
Why this matters
Testosterone therapy is one of the most common gender-affirming treatments, and it is also prescribed for cisgender men with hypogonadism — so the pharmacology matters in any future setting. The therapy is generally safe, but surveillance catches the risks that matter: rising red blood cell count (erythrocytosis, which raises clotting risk), blood pressure and lipid changes, and mental health effects. Gels add a unique safety point: the drug transfers skin-to-skin, so people using gel must protect partners, children, and pets from application sites. Exams test mechanisms (Androgen receptor The cellular target that testosterone activates Full entry → activation, aromatization) and monitoring (hematocrit); practice tests whether you can teach injection safety and gel handling.
The college version
Core Concepts
Goals of masculinizing therapy
The goal is to raise testosterone into the typical adult male range and lower estradiol. Rising testosterone drives male secondary sex characteristics; suppressing estrogen stops menstruation, which for most people happens within the first months. As with feminizing therapy, changes are gradual — months to years — and goals are individualized. Some changes are permanent (voice deepening, facial hair, clitoral enlargement); others (fat distribution, muscle mass) partially reverse if the drug is stopped.
Testosterone: the masculinizing foundation
Testosterone is a natural androgen; therapeutic use relies on the same molecule or slow-release esters. Delivery forms differ mainly in kinetics and handling:
- Injectable testosterone (depot esters): given by intramuscular or subcutaneous injection on a prescriber-set schedule; levels rise after each dose and drift down between doses, so lab timing matters.
- Transdermal gels and patches: applied daily to clean, dry skin; provide steadier levels but carry a transfer risk (see Nursing Implications).
- Buccal systems and subcutaneous pellets: less common alternatives.
All forms share the same mechanism: testosterone activates androgen receptors, driving virilizing changes. The prescriber chooses the form based on preference, cost, adherence, and risk; the nurse teaches the chosen form and reinforces that switching happens only through the prescriber.
Expected effects and their time course
Androgen-driven changes include: voice deepening (permanent, typically within the first year), facial and body hair growth (permanent but continues for years), clitoral enlargement, increased muscle mass, fat redistribution away from hips and thighs, increased libido, acne (especially early on), and cessation of menstruation (usually within the first several months). Mood and energy effects are common and usually positive, but mood changes — including worsening depression or irritability — are reportable. Fertility is affected: ovulation typically stops, and stopping testosterone does not guarantee fertility returns, so family-building options are discussed before starting.
Aromatization: why estradiol doesn't just disappear
A portion of administered testosterone is converted to estradiol by the enzyme aromatase in fat and other tissues, so estradiol levels do not fall to zero during masculinizing therapy — and that's expected. Aromatization contributes to some effects (for example, bone health) and is one reason hormone balance and bone density are monitored rather than assumed.
Monitoring and safety
Routine monitoring includes hematocrit/hemoglobin (erythrocytosis is the most important adverse effect — it raises clotting risk), lipids and blood pressure (testosterone can worsen both), bone density over time, and mental health. Testosterone is contraindicated during pregnancy — it is teratogenic — so pregnancy testing and effective contraception are part of the plan when pregnancy is possible. Teach patients to report erythrocytosis symptoms (headache, dizziness, visual changes, chest pain), blood-pressure symptoms, and mood changes.
Nursing implications
Two teaching priorities stand out. Injections: demonstrate technique, site rotation, and safe sharps disposal; remind the patient that labs are timed relative to injections, so keep appointment schedules. Gels: apply to clean, dry skin; let dry before dressing; wash hands thoroughly; cover the site; and avoid skin-to-skin contact with other people — especially children and pregnant partners — because transfer can cause effects in others. Never share gel. Also teach: don't start or stop on your own, report concerns, and keep follow-up appointments. The nurse administers and educates under prescriber orders and facility policy — scope varies by jurisdiction — and verifies all drug information against current references, the formulary, and orders.
Common Confusions
| Do Not Confuse | With | Difference |
|---|---|---|
| Testosterone therapy | Guaranteed aggression | Mood effects vary by person; "roid rage" is a myth unsupported for therapeutic doses — but mood changes are still worth monitoring and reporting |
| Gel vs. injection | "Same thing, pick either" | Same drug, different kinetics (steady vs. peaks/troughs) and very different handling and lab-timing considerations |
| Masculinizing therapy | Elimination of estrogen | Aromatase converts some testosterone to estradiol, so estrogen doesn't disappear |
| Voice change | Reversible | Deepening is permanent once it occurs — important for consent discussions |
| Testosterone | "Only for transgender people" | The same drug treats cisgender men with hypogonadism; indication differs, pharmacology doesn't |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Masculinizing therapy gives the body a hormone called testosterone, which makes changes like a deeper voice, more body hair, and stronger muscles — slowly, over months and years. Some changes stay forever, like the voice; others can change back if the medicine stops. Testosterone gel is like sunscreen you rub on skin, but it can rub off onto other people, so you have to wash your hands and cover the spot. The nurse's job is to show how to use it safely and to watch blood tests for too many red blood cells.
Worked example
J., a 28-year-old transgender man, is starting testosterone gel. The nurse teaches the routine: apply the gel each morning to clean, dry skin on the shoulders or upper arms, let it dry before dressing, and wash hands immediately. J.'s partner is pregnant — so the nurse stresses that the application site must stay covered with clothing, that J. should shower before skin-to-skin contact with his partner, and that no one else should ever touch or share the gel. The reportable-symptom list follows: new or worsening headaches, dizziness, blurred vision, or chest pain (possible erythrocytosis), and any low mood. Finally, the nurse confirms the prescriber's plan for follow-up blood work — hematocrit, lipids, and blood pressure on a prescriber-set schedule. Clinical reasoning: the highest-yield teaching is transfer prevention — a pregnant partner exposed to testosterone gel is a genuine teratogenic risk — followed by erythrocytosis warning signs. The nurse translates the prescriber's plan into daily behaviors, not decisions about the regimen.
Key takeaways
- The drug is testosterone, available as injectables, gels/patches, buccal, and pellets — same androgen receptor mechanism, different kinetics and handling.
- Mechanism: androgen receptor activation → virilizing effects; a portion converts to estradiol via aromatase (estradiol doesn't vanish — that's expected).
- Permanent changes: voice deepening, facial hair, clitoral enlargement. Partially reversible: fat distribution, muscle mass, menses (which stop in most people within months of starting).
- Erythrocytosis (rising hematocrit) is the key adverse effect — teach headache, dizziness, visual changes, chest pain as reportable symptoms.
- Also monitor: blood pressure, lipids, bone density, mental health/mood.
- Testosterone is teratogenic — contraindicated in pregnancy; contraception and fertility discussions happen before starting.
- Gel teaching: wash hands, cover the site, avoid skin-to-skin transfer to others (especially children and pregnant partners); never share.
- Educational draft: classes and mechanisms only; verify all dosing, lab targets, and monitoring schedules against current references, formulary, and prescriber orders; scope varies by jurisdiction and facility.
Check yourself
5 review questions from the chapter. Try each one, then open the answer.
What is the primary drug in masculinizing therapy, and how does it produce its effects?
Show answer
Testosterone, given in injectable, transdermal, buccal, or pellet forms. It activates androgen receptors in target tissues to produce virilizing changes.
Why does estradiol not fall to zero during testosterone therapy?
Show answer
Because the enzyme aromatase converts a portion of testosterone into estradiol — some estrogen production continues by design.
What is the most important adverse effect to monitor, and what symptoms should patients report?
Show answer
Erythrocytosis (elevated hematocrit), which raises clotting risk. Teach patients to report headache, dizziness, visual changes, and chest pain, plus mood changes.
Name two permanent and two partially reversible changes of masculinizing therapy.
Show answer
Permanent: voice deepening, facial/body hair growth, clitoral enlargement. Partially reversible: fat distribution, muscle mass, and menstruation pattern if therapy stops.
What is the key safety teaching point for transdermal testosterone gel?
Show answer
Prevent transfer to others: wash hands after application, cover the site with clothing, avoid skin-to-skin contact with children and pregnant partners, and never share the gel.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Testosterone
- The main human androgen; the drug used in masculinizing therapy
- Androgen receptor
- The cellular target that testosterone activates
- Aromatase
- The enzyme that converts testosterone into estradiol
- Erythrocytosis
- Too many red blood cells (elevated hematocrit)
- Depot injection
- An injectable form that releases drug slowly over time
- Transdermal gel
- Testosterone applied to skin daily
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.